Choline, an alpha7 nicotinic acetylcholine receptor agonist, alleviates hyperalgesia in a rat osteoarthritis model

Neuroscience Letters

Volumn 548, Issue , 2013, Pages 291-295

  Lee, Seo Eun ^a  

^a Hanyang University   (South Korea)

Author keywords

Alpha7 nicotinic acetylcholine receptor; Choline; Monoiodoacetic acid; Osteoarthritis; Pain

Indexed keywords

BUNGAROTOXIN RECEPTOR; CHOLINE; IODOACETIC ACID; METHYLLYCACONITINE; SODIUM CHLORIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CHRONIC INFLAMMATORY PAIN; CHRONIC PAIN; HYPERALGESIA; INFLAMMATORY PAIN; KNEE; NONHUMAN; OSTEOARTHRITIS; PAIN ASSESSMENT; PAW WITHDRAWAL LATENCY; PAW WITHDRAWAL THRESHOLD; PRIORITY JOURNAL; RAT; SYNOVIUM;

ALPHA7 NICOTINIC ACETYLCHOLINE RECEPTOR; CHOLINE; MONOIODOACETIC ACID; OSTEOARTHRITIS; PAIN;

ALPHA7 NICOTINIC ACETYLCHOLINE RECEPTOR; ANIMALS; ARTHRALGIA; CHOLINE; HYPERALGESIA; MALE; OSTEOARTHRITIS; RATS; RATS, SPRAGUE-DAWLEY; SPINAL CORD; TREATMENT OUTCOME;

EID: 84880137314     PISSN: 03043940     EISSN: 18727972     Source Type: Journal    
DOI: 10.1016/j.neulet.2013.05.073     Document Type: Article

References (36)

1. Abdin M.J., Morioka N., Morita K., Kitayama T., Kitayama S., Nakashima T., Dohi T. Analgesic action of nicotine on tibial nerve transection (TNT)-induced mechanical allodynia through enhancement of the glycinergic inhibitory system in spinal cord. Life. Sci. 2006, 80:9-16.
2. Andersson J. The inflammatory reflex - introduction. J. Intern. Med. 2005, 257:122-125.
3. Burnham L.J., Dickenson A.H. The anti-nociceptive effect of milnacipran in the monosodium iodoacetate model of OA pain and its relation to changes in descending inhibition. J. Pharmacol. Exp. Ther. 2013, 344:696-707.
4. Combe R., Bramwell S., Field M.J. The monosodium iodoacetate model of osteoarthritis: a model of chronic nociceptive pain in rats?. Neurosci. Lett. 2004, 370:236-240.
5. Couture R., Harrisson M., Vianna R.M., Cloutier F. Kinin receptors in pain and inflammation. Eur. J. Pharmacol. 2001, 429:161-176.
6. Damaj M.I., Meyer E.M., Martin B.R. The antinociceptive effects of alpha7 nicotinic agonists in an acute pain model. Neuropharmacology 2000, 39:2785-2791.
7. Decker M.W., Rueter L.E., Bitner R.S. Nicotinic acetylcholine receptor agonists: a potential new class of analgesics. Curr. Top. Med. Chem. 2004, 4:369-384.
8. Feitas K., Carroll F.I., Damaj M.I. The antinociceptive effects of nicotinic receptors alpha 7 positive allosteric modulators in murine acute and tonic pain models. J. Pharmacol. Exp. Ther. 2012, 344:264-275.
9. Felson D.T., Lawrence R.C., Dieppe P.A., Hirsch R., Helmick C.G., Jordan J.M., Kington R.S., Lane N.E., Nevitt M.C., Zhang Y., Sowers M., McAlindon T., Spector T.D., Poole A.R., Yanovski S.Z., Ateshian G., Sharma L., Buckwalter J.A., Brandt K.D., Fries J.F. Osteoarthritis: new insights. Part 1. The disease and its risk factors. Ann. Intern. Med. 2000, 133:635-646.
10. Ferreira-Gomes J., Adaes S., Sousa R.M., Mendonca M., Castro-Lopes J.M. Dose-dependent expression of neuronal injury markers during experimental osteoarthritis induced by monoiodoacetate in the rat. Mol. Pain 2012, 8:50.
11. Feuerbach D., Lingenhoehl K., Olpe H.R., Vassout A., Gentsch C., Chaperon F., Nozulak J., Enz A., Bilbe G., McAllister K., Hoyer D. The selective nicotinic acetylcholine receptor alpha7 agonist JN403 is active in animal models of cognition, sensory gating, epilepsy and pain. Neuropharmacology 2009, 56:254-263.
12. Giunta B., Ehrhart J., Townsend K., Sun N., Vendrame M., Shytle D., Tan J., Fernandez F. Galantamine and nicotine have a synergistic effect on inhibition of microglial activation induced by HIV-1 gp120. Brain. Res. Bull. 2004, 64:165-170.
13. Gurun M.S., Parker R., Eisenach J.C., Vincler M. The effect of peripherally administered CDP-choline in an acute inflammatory pain model: the role of alpha7 nicotinic acetylcholine receptor. Anesth. Analg. 2009, 108:1680-1687.
14. Guzman R.E., Evans M.G., Bove S., Morenko B., Kilgore K. Mono-iodoacetate-induced histologic changes in subchondral bone and articular cartilage of rat femorotibial joints: an animal model of osteoarthritis. Toxicol. Pathol. 2003, 31:619-624.
15. Hurst R., Rollema H., Bertrand D. Nicotinic acetylcholine receptors: from basic science to therapeutics. Pharmacol. Ther. 2013, 137:22-54.
16. Kalbhen D.A. Chemical model of osteoarthritis--a pharmacological evaluation. J. Rheumatol. 1987, 14:130-131. Spec. No.
17. Kidd B.L. Osteoarthritis and joint pain. Pain 2006, 123:6-9.
18. Kiguchi N., Kobayashi Y., Maeda T., Tominaga S., Nakamura J., Fukazawa Y., Ozaki M., Kishioka S. Activation of nicotinic acetylcholine receptors on bone marrow-derived cells relieves neuropathic pain accompanied by peripheral neuroinflammation. Neurochem. Int. 2012, 61:1212-1219.
19. Loram L.C., Harrison J.A., Chao L., Taylor F.R., Reddy A., Travis C.L., Giffard R., Al-Abed Y., Tracey K., Maier S.F., Watkins L.R. Intrathecal injection of an alpha seven nicotinic acetylcholine receptor agonist attenuates gp120-induced mechanical allodynia and spinal pro-inflammatory cytokine profiles in rats. Brain Behav. Immun. 2010, 24:959-967.
20. Medhurst S.J., Hatcher J.P., Hille C.J., Bingham S., Clayton N.M., Billinton A., Chessell I.P. Activation of the alpha7-nicotinic acetylcholine receptor reverses complete freund adjuvant-induced mechanical hyperalgesia in the rat via a central site of action. J. Pain 2008, 9:580-587.
21. Millar N.S., Gotti C. Diversity of vertebrate nicotinic acetylcholine receptors. Neuropharmacology 2009, 56:237-246.
22. Mohan G., Perilli E., Kuliwaba J.S., Humphries J.M., Parkinson I.H., Fazzalari N.L. Application of in vivo micro-computed tomography in the temporal characterisation of subchondral bone architecture in a rat model of low-dose monosodium iodoacetate-induced osteoarthritis. Arthritis Res. Ther. 2011, 13:R210.
23. Munro G., Hansen R., Erichsen H., Timmermann D., Christensen J., Hansen H. The alpha7 nicotinic ACh receptor agonist compound B and positive allosteric modulator PNU-120596 both alleviate inflammatory hyperalgesia and cytokine release in the rat. Br. J. Pharmacol. 2012, 167:421-435.
24. Nagase H., Kumakura S., Shimada K. Establishment of a novel objective and quantitative method to assess pain-related behavior in monosodium iodoacetate-induced osteoarthritis in rat knee. J. Pharmacol. Toxicol. Methods 2012, 65:29-36.
25. Nirogi R., Jabaris S.L., Jayarajan P., Abraham R., Shanmuganathan D., Rasheed M.A., Royapalley P.K., Goura V. Antinociceptive activity of alpha4beta2* neuronal nicotinic receptor agonist A-366833 in experimental models of neuropathic and inflammatory pain. Eur. J. Pharmacol. 2011, 668:155-162.
26. Ogbonna A.C., Clark A.K., Gentry C., Hobbs C., Malcangio M. Pain-like behaviour and spinal changes in the monosodium iodoacetate model of osteoarthritis in C57Bl/6 mice. Eur. J. Pain 2013, 17:514-526.
27. Orita S., Ishikawa T., Miyagi M., Ochiai N., Inoue G., Eguchi Y., Kamoda H., Arai G., Toyone T., Aoki Y., Kubo T., Takahashi K., Ohtori S. Pain-related sensory innervation in monoiodoacetate-induced osteoarthritis in rat knees that gradually develops neuronal injury in addition to inflammatory pain. BMC Musculoskelet. Disord. 2011, 12:134.
28. Piscaer T.M., Muller C., Mindt T.L., Lubberts E., Verhaar J.A., Krenning E.P., Schibli R., De Jong M., Weinans H. Imaging of activated macrophages in experimental osteoarthritis using folate-targeted animal single-photon-emission computed tomography/computed tomography. Arthritis Rheum. 2011, 63:1898-1907.
29. Sagar D.R., Burston J.J., Hathway G.J., Woodhams S.G., Pearson R.G., Bennett A.J., Kendall D.A., Scammell B.E., Chapman V. The contribution of spinal glial cells to chronic pain behaviour in the monosodium iodoacetate model of osteoarthritic pain. Mol. Pain 2011, 7:88.
30. Shytle R.D., Mori T., Townsend K., Vendrame M., Sun N., Zeng J., Ehrhart J., Silver A.A., Sanberg P.R., Tan J. Cholinergic modulation of microglial activation by alpha 7 nicotinic receptors. J. Neurochem. 2004, 89:337-343.
31. Tassonyi E., Charpantier E., Muller D., Dumont L., Bertrand D. The role of nicotinic acetylcholine receptors in the mechanisms of anesthesia. Brain Res. Bull. 2002, 57:133-150.
32. Thakur M., Rahman W., Hobbs C., Dickenson A.H., Bennett D.L. Characterisation of a peripheral neuropathic component of the rat monoiodoacetate model of osteoarthritis. PLoS ONE 2012, 7:e33730.
33. van Baar M.E., Dekker J., Lemmens J.A., Oostendorp R.A., Bijlsma J.W. Pain and disability in patients with osteoarthritis of hip or knee: the relationship with articular, kinesiological, and psychological characteristics. J. Rheumatol. 1998, 25:125-133.
34. Wang Y., Su D.M., Wang R.H., Liu Y., Wang H. Antinociceptive effects of choline against acute and inflammatory pain. Neuroscience 2005, 132:49-56.
35. Wilson A.W., Medhurst S.J., Dixon C.I., Bontoft N.C., Winyard L.A., Brackenborough K.T., De Alba J., Clarke C.J., Gunthorpe M.J., Hicks G.A., Bountra C., McQueen D.S., Chessell I.P. An animal model of chronic inflammatory pain: pharmacological and temporal differentiation from acute models. Eur. J. Pain 2006, 10:537-549.
36. Xie L., Lin A.S., Kundu K., Levenston M.E., Murthy N., Guldberg R.E. Quantitative imaging of cartilage and bone morphology, reactive oxygen species, and vascularization in a rodent model of osteoarthritis. Arthritis Rheum. 2012, 64:1899-1908.